Status: Not yet recruiting
To Evaluate the Performance and Safety of RisoR Crest Everolimus Eluting Coronary Stent System
The study will evaluate the performance and safety of RisoR Crest Everolimus Eluting Coronary Stent System. A total of 2000 participants will be included in the study from India and Italy.
Participants needed: 2,000
Trial details
Age: 18-99Biological sex: AllType: InterventionalSponsor: Poly Medicure LimitedUpdated: Aug 1, 2025
Eligibility criteria
Age more than 18 years [+6]
Pregnant and lactating females [+10]